CSF1R and B-cell chronic lymphocytic leukemia: These findings led to a hypothesis whereby CSF1R inhibitors act indirectly on CLL leukemic cells via direct inhibition of CSF1R-expressing monocytes, suggesting that the presence of varying levels of CSF1R-expressing monocytes may correlate with varying degrees of CSF1R inhibitor sensitivity.